Try our Advanced Search for more refined results
Ipsen SA
-
Order | Filed: May 03, 2024 | Entered: May 03, 2024 Radius Health, Inc. et al v. Orbicular Pharmaceutical Technologies Private Limited
Patent - Abbreviated New Drug Application(ANDA) | Massachusetts
Order
Judge Richard G. Stearns: ELECTRONIC ORDER entered re 129 Stipulation. The court construes the parties' stipulation as a motion to amend the pretrial schedule and, because the requested changes are minor, will allow it. Reply reports must be exchanged by 7/12/2024 and expert discovery will close 8/2/2024. All other pretrial deadlines remain as currently scheduled. (RGS, law3)
-
Misc | Filed: May 03, 2024 | Entered: May 03, 2024 Radius Health, Inc. et al v. Orbicular Pharmaceutical Technologies Private Limited
Patent - Abbreviated New Drug Application(ANDA) | Massachusetts
Stipulation
STIPULATION Regarding Expert Schedule and Proposed Order by Ipsen Pharma S.A.S., Radius Health, Inc.. (Marandett, Eric)
-
Service | Filed: May 01, 2024 | Entered: May 01, 2024 IPSEN BIOPHARMACEUTICALS, INC. et al v. CONJUPRO BIOTHERAPEUTICS, INC. et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Waiver of Service Executed
WAIVER OF SERVICE Returned Executed by IPSEN BIOPHARMACEUTICALS, INC., IPSEN BIOPHARM LTD.. CONJUPRO BIOTHERAPEUTICS, INC. waiver sent on 4/23/2024, answer due 6/24/2024. (LIZZA, CHARLES)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login